Target intelligence / Profile preview

Family with sequence similarity 230 member D (FAM230D)

Target
FAM230D
Molecular classification
Other (specifically, long intergenic non-coding RNA / lincRNA)
01

Overview

FAM230D is a member of the FAM230 gene family, defined by sequence similarity in particular chromosomal regions (notably chromosome 22 LCRs/LCR22s). It is annotated as a long intergenic non-coding RNA (lincRNA) gene, meaning it is transcribed but does not encode a protein product^5. These lincRNA genes are part of a repeated genomic structure involving clincRNA sequences, spacers, and pseudogenes, which are implicated in gene family expansion and chromosomal segmental duplications. The specific biological function of FAM230D remains uncharacterized; related FAM230 lincRNAs exhibit tissue-specific expression (e.g., testes and fetal heart) and may be involved in development, but direct evidence for regulatory roles or disease association is lacking^5. FAM230D should not be confused with similarly named protein-coding genes (e.g., FAM83D) that are implicated as cancer biomarkers or therapeutic targets[1][3]. No drugs, mechanisms of action, or clinical safety data have been reported for FAM230D due to its non-coding RNA nature^5.

Other names
AC008079.1
02

Biological functions

Other (no protein-coding function; may play roles in gene regulation; specific functional annotation lacking or uncharacterized)
03

Disease associations

Other (possible involvement in chromosomal structure evolution and gene family formation; no direct evidence for roles in cancer, inflammation, or other specific diseases)

Beyond the preview

Go deeper on Family with sequence similarity 230 member D (FAM230D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 230 member D (FAM230D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call